Table of Contents
Highlights from Medical Grand Rounds
- Thromboembolic disease: underdiagnosed, undertreated, deadly
What should you be looking for in your nonambulatory hospitalized patients? A capsulization of current concepts in diagnosis, treatment, and prevention of this problem.
- Medical treatment of pituitary tumors
A brief review of appropriate drug therapy in hyperprolactinemia, prolactinoma, and acromegaly.
Internal Medicine Board Review
- A woman with amenorrhea and galactorrhea
The author guides the reader through a challenging diagnosis.
Cancer Diagnosis and Management
- Common complications and emergencies associated with cancer and its therapy
An update on management of superior vena cava syndrome, malignant pericardial effusions, hypercalcemia, tumor lysis syndrome, febrile neutropenia, and other problems.
Review
- The search for diagnostic criteria in Alzheimer’s disease: an update
Although much is known of the histopathologic findings in this disease, definitive diagnostic criteria are still lacking.
Cardiology Dialogues
- Dilate or debulk?
In this first in a new series of informal dialogues on controversial and emerging topics in cardiac diagnosis and therapy, two internationally known investigators tally the relative merits of atherectomy and angioplasty for percutaneous therapy of coronary artery disease.
Original Study
- Pleural changes in malignant pleural effusions: appearance on computed tomography
CT scanning appears to facilitate demonstration of several features that should arouse the clinician’s and radiologist’s suspicion of pleural malignancy.
- Attitudes toward childbearing and changes in sexual and contraceptive practices among HIV-infected women
After studying 46 women with HIV infection, the authors found that counseling often was not adequate and that, though sexual practices changed, further study is needed to see if these changes are sustained.
Case Report
Editorial
- Influencing health behavior: physicians as agents of change
Physicians’ rediscovery of their role as educators, not simply interventionists, is the key to the medicine of the future.